Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug;36(8):660.
doi: 10.1002/kjm2.12249. Epub 2020 Jun 12.

Pharmacist's perspective on HCQ treatment of COVID-19

Affiliations
Comment

Pharmacist's perspective on HCQ treatment of COVID-19

Ya-Ling Wang et al. Kaohsiung J Med Sci. 2020 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors declare no conflict of interest.

Comment on

References

    1. McChesney EW, Banks WF Jr, Fabian RJ. Tissue distribution of chloroquine, hydroxychloroquine, and desethylchloroquine in the rat. Toxicol Appl Pharmacol. 1967;10:501–513. - PubMed
    1. Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Clin Infect Dis. 2020. 10.1093/cid/ciaa237. - DOI - PMC - PubMed
    1. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial. Int J Antimicrob Agents. 2020. 10.1016/j.ijantimicag.2020.105949. - DOI - PMC - PubMed
    1. Molina JM, Delaugerre C, Goff JL, Mela‐Lima B, Ponscarme D, Goldwirt L, et al. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID‐19 infection. Med Mal Infect. 2020;50:384. - PMC - PubMed
    1. Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G, et al. Observational study of hydroxychloroquine in hospitalized patients with COVID‐19. N Engl J Med. 2020. 10.1056/NEJMoa2012410. - DOI - PMC - PubMed